Skip to main content

Table 1 Results LBC versus histology and HPV testing

From: A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off

  

Primary Histology (N = 139)

 
 

Not performed

Normal

Borderline

CIN1

CIN2

CIN3+

Total

LBC

N(Cer+,HC2+)

N(Cer+,HC2+)

N(Cer+,HC2+)

N(Cer+,HC2+)

N(Cer+,HC2+)

N(Cer+,HC2+)

N(Cer+, HC2+)

Normal (Pap I/II)

1,208 (130, 69)

0

0

0

0

0

1,208 (130, 69)

ASC-US (Pap IIw)

65 (20, 18)

0

0

0

0

0

65 (20, 18)

ASC-H, AGUS (Pap III)

14 (6, 5)

0

1 (0, 0)

0

0

5 (4, 4)

20 (10, 9)

LSIL, HSIL (Pap IIID)

312 (197, 211)

21 (16, 18)

1 (1, 1)

5 (4, 4)

13 (12, 13)

20 (20, 20)

372 (250, 267)

HSIL, CIS (Pap IVa)

3 (3, 3)

1 (1, 1)

0

3 (3, 3)

6 (6, 6)

58 (56, 58)

71 (69, 71)

HSIL, CIS, Micro (IVb)

0

0

0

0

0

2 (2, 2)

2 (2,2)

Microinvasive (Pap V)

0

0

0

0

0

3 (3, 3)

3 (3, 3)

Total

1,602 (356, 306)

22 (17, 19)

2 (1, 1)

8 (7, 7)

19 (18, 19)

88 (85, 87)

1,741 (484, 439)

  1. Cer+: Cervista positive; HC2+: HC2 positive.